BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17906197)

  • 1. The graying of testis cancer patients: what have we learned?
    Bajorin DF
    J Clin Oncol; 2007 Oct; 25(28):4341-3. PubMed ID: 17906197
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis].
    Bokemeyer C; Kuczyk MA; Köhne CH; Haupt A; Schmoll HJ
    Med Klin (Munich); 1996 Nov; 91(11):703-10. PubMed ID: 9036294
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
    van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivorship and complications of treatment in breast cancer.
    Mrozek E; Shapiro CL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):211-22, 238. PubMed ID: 16166992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
    van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late effects of treatment for germ cell tumors during childhood and adolescence.
    Hale GA; Marina NM; Jones-Wallace D; Greenwald CA; Jenkins JJ; Rao BN; Luo X; Hudson MM
    J Pediatr Hematol Oncol; 1999; 21(2):115-22. PubMed ID: 10206457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary neoplasms following treatment of malignant germ cell tumors.
    Bokemeyer C; Schmoll HJ
    J Clin Oncol; 1993 Sep; 11(9):1703-9. PubMed ID: 8394879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.
    Haugnes HS; Bosl GJ; Boer H; Gietema JA; Brydøy M; Oldenburg J; Dahl AA; Bremnes RM; Fosså SD
    J Clin Oncol; 2012 Oct; 30(30):3752-63. PubMed ID: 23008318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term complications of therapy for testicular cancer.
    Kaufman MR; Chang SS
    Urol Clin North Am; 2007 May; 34(2):259-68; abstract xi. PubMed ID: 17484931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late complications of therapy of Hodgkin's disease: prevention and management.
    Ng AK; Mauch PM
    Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of germ cell tumors of the adult testis at the Memorial Sloan Kettering Cancer Center.
    Whitmore WF; Bosl G
    Acta Urol Belg; 1985; 53(2):341-61. PubMed ID: 2990181
    [No Abstract]   [Full Text] [Related]  

  • 13. Is a contralateral testicular biopsy in patients with unilateral germ cell testicular cancer indicated as a routine procedure?
    von der Maase H
    Acta Oncol; 2005; 44(6):523-5. PubMed ID: 16165909
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
    Friedberg JW
    Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicity of treatment of germ cell tumors.
    Boyer M; Raghavan D
    Semin Oncol; 1992 Apr; 19(2):128-42. PubMed ID: 1313191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumours induced by radiotherapy and chemotherapy].
    Coulange C; Davin JL;
    Prog Urol; 2002 Jun; 12(3):510-6. PubMed ID: 12189769
    [No Abstract]   [Full Text] [Related]  

  • 17. [Testicular cancer: should the contralateral testis be assessed?].
    Weissbach L
    Urologe A; 1992 Jul; 31(4):197-8. PubMed ID: 1325081
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary malignant neoplasms in testicular cancer survivors.
    Curreri SA; Fung C; Beard CJ
    Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expected "boomerang effect"?
    Perilongo G
    Pediatr Blood Cancer; 2006 Jul; 47(1):1. PubMed ID: 16395680
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term survivors of testicular cancer.
    Tamboli CP
    J Clin Oncol; 2003 Oct; 21(20):3888; author reply 3888-9. PubMed ID: 14551316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.